Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Gastroenterology|August 29, 2002
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's diseaseMaria T Abreu, Kent D Taylor, Ying-Chao Lin, et al.
Inflammatory Bowel Diseases|January 30, 2007
Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associationsKonstantinos A Papadakis, Huiying Yang, Andrew Ippoliti, et al.
Human Vaccines & Immunotherapeutics|August 27, 2015
Intranasal nanoemulsion-based inactivated respiratory syncytial virus vaccines protect against viral challenge in cotton ratsJessica J O'Konek, Paul E Makidon, Jeffrey J Landers, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Enhanced mucosal B- and T-cell responses against SARS-CoV-2 after heterologous intramuscular mRNA prime/intranasal protein boost vaccination with a combination adjuvantGabriel Laghlali, Matthew J Wiest, Dilara Karadag, et al.
Inflammatory Bowel Diseases|March 11, 2011
Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behaviorGary R Lichtenstein, Stephan R Targan, Marla C Dubinsky, et al.
NPJ Vaccines|June 29, 2023
Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged miceSonia Jangra, Jeffrey J Landers, Gabriel Laghlali, et al.
Journal of Clinical Gastroenterology|December 13, 2005
Treatment with infliximab is associated with increased markers of bone formation in patients with Crohn's diseaseMaria T Abreu, Jordan L Geller, Eric A Vasiliauskas, et al.
Plos One|August 14, 2008
Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccinePaul E Makidon, Anna U Bielinska, Shraddha S Nigavekar, et al.
Pageof 17